Shatavari root extract combined with Ashwagandha root extract improves sexual arousal, lubrication, orgasm, and total Female Sexual Function Index scores in women.
In an 8-week randomized, double-blind, placebo-controlled trial with 135 women, the combination of Shatavari and Ashwagandha root extracts (SHT-ARE) significantly improved FSFI Arousal (P = 0.041), Lubrication (P = 0.027), Orgasm (P = 0.031), and Total FSFI (P = 0.005) scores compared to placebo. The SHT-ARE group also showed reduced sexual distress (FSDS, P < 0.0001), increased happiness (OHQ, P < 0.0001), and improved mood (POMS, P < 0.0001) versus placebo.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Shatavari root extract combined with Ashwagandha root extract improves sexual arousal, lubrication, orgasm, and total Female Sexual Function Index scores in women. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
Shatavari root extract combined with Ashwagandha root extract improves sexual arousal, lubrication, orgasm, and total Female Sexual Function Index scores in women.
This conclusion is most relevant to: 135 women with sexual health concerns.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effects of Shatavari (Asparagus racemosus) Root Extract on Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-Arm, Parallel-Group, Placebo-Controlled Study. (International journal of women's health, 2026) —
How It Works
The proposed biological pathway:
- ▸Shatavari and Ashwagandha are classified as Rasayanas in Ayurveda, traditionally used to promote reproductive health
- ▸The combination may modulate stress and mood via Ashwagandha's adaptogenic properties
- ▸Improved mood and reduced distress may enhance sexual response and satisfaction
- ▸Result: Improved sexual function, happiness, and mood in women
Who Might Benefit
Evidence fit by population:
- ▸135 women with sexual health concerns
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Only abstract data available; full study details on dosing, randomization, and blinding procedures are not provided
- ▸No significant improvement in overall PSQI sleep quality was observed except for sleep efficiency, limiting conclusions about sleep effects
- ▸The study duration was only 8 weeks, which may not capture long-term efficacy or safety
Frequently Asked Questions
What is Shatavari and how does it affect women's sexual health?▼
Shatavari (Asparagus racemosus) is an Ayurvedic herb traditionally used to support female reproductive health. This study found that a standardized root extract, especially when combined with Ashwagandha, improved sexual arousal, lubrication, orgasm, and overall sexual function in women over 8 weeks.
Did the Shatavari supplement improve sleep quality?▼
The study measured sleep using the Pittsburgh Sleep Quality Index (PSQI). Only sleep efficiency showed a significant improvement in the Shatavari plus Ashwagandha group compared to placebo; overall PSQI scores were not significantly different.
Was the Shatavari supplement safe?▼
Yes, all reported adverse events were mild and resolved without intervention. The study monitored liver, thyroid, and renal function markers and found no safety concerns.
How was sexual function measured in this study?▼
The primary outcome was the Female Sexual Function Index (FSFI), a validated questionnaire assessing desire, arousal, lubrication, orgasm, satisfaction, and pain. Secondary measures included the Female Sexual Distress Scale (FSDS) and number of satisfying sexual events.
References
- 1.Ademola J, Mahajan S, Srivathsan M, Langade D. “Effects of Shatavari (Asparagus racemosus) Root Extract on Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-Arm, Parallel-Group, Placebo-Controlled Study..” International journal of women's health, 2026. PMID: 41710148 DOI: 10.2147/IJWH.S561213